Identity and percentage holding of significant shareholders
Substantial holdings | Shares held | % |
---|---|---|
Directors and related shareholders | ||
Ian Gilham | 614,295 | 0.66% |
David Budd | 293,710 | 0.32% |
Tom Lindsay | 262,717 | 0.28% |
Chris Yates | 67,554 | 0.07% |
Total Directors' holdings | 1,238,276 | 1.34% |
Total shares in issue | 92,542,446 | 100.00% |
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 92,542,446.
Number of AIM securities not in public hands is 1,238,276 or 1.3%.
Text updated: 28/11/2022
Latest reports

05 December 2022
Annual Report and Accounts 2022
Investor News
Friday December 23, 2022
Week ahead: All quiet on the post-Christmas front
Monday November 21, 2022
Genedrive slumps on higher full year losses
Friday November 18, 2022